Gene therapy for retinal dystrophy: The Lancet: January 5, 2018
The Lancet in conversation with - Un pódcast de The Lancet Group - Viernes
Categorías:
Rebecca Cooney discusses the newly FDA-approved gene therapy for treating loss of vision as a result of retinal dystrophy.Continue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
